U.S. market Open. Closes in 1 hour 23 minutes

VTYX | Ventyx Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue941.00K470.00K30.00KN/AN/A
Gross Profit-941.00K-470.00K-30.00KN/AN/A
Operating Expenses207.99M113.14M67.15M7.05M4.18M
Selling, General & Admin32.23M25.40M8.67M684.00K628.00K
Research & Development175.77M87.74M58.48M6.37M3.55M
Other Operating Expenses041.00K-5.45M-1.00K-1.00K
Operating Income-207.99M-113.14M-67.15M-7.05M-4.18M
Other Expenses / Income15.03M4.71M-16.60M-21.12M-147.00K
Before Tax Income-192.96M-108.43M-83.75M-28.17M-4.33M
Income Tax ExpensesN/A-470.00K-5.38M358.00K146.00K
Net Income-192.96M-107.96M-78.37M-28.53M-4.47M
Interest ExpensesN/AN/A99.00K358.00K146.00K
Basic Shares Outstanding58.54M52.47M50.41M50.30M50.30M
Diluted Shares Outstanding58.54M52.47M50.41M50.30M50.30M
EBITDA-207.99M-107.96M-67.12MN/A-1.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-192.96M-108.43M-83.65M-27.82M-4.18M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙